
USA - NASDAQ:MYL -
The current stock price of MYL is 15.855 null. In the past month the price increased by 2.82%. In the past year, price decreased by -8.56%.
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Mylan NV Ord Shs
1000 MYLAN BOULEVARD
CANONSBURG PA 15317
CEO: Heather Bresch
Phone: 724-514-1800
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
The current stock price of MYL is 15.855 null. The price increased by 1.96% in the last trading session.
MYL does not pay a dividend.
MYL has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
The PE ratio for Mylan NV Ord Shs (MYL) is 3.35. This is based on the reported non-GAAP earnings per share of 4.73 and the current share price of 15.855 null.
ChartMill assigns a technical rating of 4 / 10 to MYL. When comparing the yearly performance of all stocks, MYL is a bad performer in the overall market: 78.99% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to MYL. While MYL is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months MYL reported a non-GAAP Earnings per Share(EPS) of 4.73. The EPS increased by 9.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.31% | ||
| ROA | 0.85% | ||
| ROE | 2.12% | ||
| Debt/Equity | 0.8 |